Multiple myeloma (MM) is characterized by copy number abnormalities (CNAs), some of which influence patient outcomes and are sometimes observed only...

La medicina di precisione costituisce un approccio particolarmente rilevante in ambito oncologico, relativamente a tumore e microambiente tumorale...

Circulating tumor DNA (ctDNA) has offered a minimally invasive approach for the detection and measurement of cancer

Therefore, systemic study on IgD MM is purposeful to disclose the recurrent and refractory features in both IgD and other types of MM, and beneficial...

Extensive genetic and transcriptional characterization of myeloma has identified subtypes with prognostic and therapeutic implications. In contrast...

Despite the improvement of therapeutic regimens, several patients with multiple myeloma (MM) still experience early relapse (ER). This subset of...

This retrospective cohort study used 2013-2018 commercial and Medicare claims data to assess medication use in adults with MM

To evaluate impact of time to transplant on subsequent outcomes, we analyzed data on consecutive MM patients who received novel agents-based induction...

Lo studio TEAMM (Tackling Early Morbidity and Mortality in Myeloma) è stato utilizzato per valutare i percorsi diagnostici nei pazienti con mieloma e...

È stata effettuata una revisione sistematica della letteratura sui database PubMed, Cochrane Library, EMBASE, Scopus e Web of Science

L’analisi degli outcome degli studi clinici oltre che l’uniformità dell’eleggibilità aiuta a determinare se un dato paziente dovrebbe essere preso in...

Gli autori si sono posti l’obiettivo di descrivere la popolazione di pazienti con mieloma multiplo nel real- world in Alberta, esaminando le...